Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial.
about
First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study.A Review of Systemic Treatment in Metastatic Triple-Negative Breast CancerEribulin in the Management of Advanced Breast Cancer: Implications of Current Research FindingsSalvage chemotherapy with gemcitabine and oxaliplatin in heavily pretreated patients with metastatic breast cancer: a multicenter phase II study.Gemcitabine-oxaliplatin combination in heavily pretreated metastatic breast cancer: a pilot study on 43 patients.Gemcitabine plus capecitabine combination in metastatic breast cancer patients previously treated with anthracyclines and taxanes.Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer.Gemcitabine and cisplatin combination regimen in patients with anthracycline- and taxane-pretreated metastatic breast cancer.A systematic review of gemcitabine and taxanes combination therapy randomized trials for metastatic breast cancer.Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer.A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocol.Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer.Mistletoe and gemcitabine in patients with advanced cancer: a model for the phase I study of botanicals and botanical-drug interactions in cancer therapy.Gemcitabine-induced severe pulmonary toxicity.Advances in the management of metastatic breast cancer: options beyond first-line chemotherapy.Gemcitabine in metastatic breast cancer.Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer: results of a multicenter phase II study.Current approaches to the management of Her2-negative metastatic breast cancer.Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancerRole of chemotherapy in breast cancer.Role of gemcitabine in cancer therapy.Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study.Phase II study of gemcitabine plus cisplatin in patients with anthracycline- and taxane- pretreated metastatic breast cancer.International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.Gemcitabine single or combination chemotherapy in post anthracycline and taxane salvage treatment of metastatic breast cancer: retrospective analysis of 124 patients.A systematic review on topoisomerase 1 inhibition in the treatment of metastatic breast cancer.One year of complete clinical response in a metastatic breast cancer patient treated with a combination of lapatinib and gemcitabine.Is gemcitabine cost effective in cancer treatment?Identification and analysis of single-nucleotide polymorphisms in the gemcitabine pharmacologic pathway.Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure.Cholesterol derivative-based liposomes for gemcitabine delivery: preparation, in vitro, and in vivo characterization.Phase I clinical and pharmacokinetic study of PM01183 (a tetrahydroisoquinoline, Lurbinectedin) in combination with gemcitabine in patients with advanced solid tumors.Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy.Therapeutic options for metastatic breast cancer
P2860
Q24812405-70561588-83A4-4EC9-9B8C-3A48CD6424AFQ26752846-5F9C8EAF-214B-4217-A9C8-9B535B08A0ECQ26774097-92706F64-4912-43A9-90AC-1FA32DF12AB7Q33373017-17C4DCB9-5BD2-4709-8E01-6B50FD3D4CFBQ33374338-1C6B9603-0FE7-46EC-AF65-8B10C90BFC72Q33378298-D409EE73-DA40-4ED5-B952-82BA33FF17E6Q33379805-E802FEEF-3678-4BA6-AA82-447A3408ABABQ33393809-710933BF-145A-43EA-A1E4-B0C2DF59CFF4Q33423308-7CC60C89-B665-4C5B-9A4B-8BC2EB4168C8Q34746035-5F7FF3A6-C7FF-4AC5-B1A7-63B3D8A21D9BQ35125726-A098CD17-2713-4BAC-8E24-A03813DFE739Q35599745-8A298F28-4988-4196-9577-6B571C2ADEB4Q35624530-079D0A92-D3C5-4878-988A-EA1CCABE6DAFQ35641366-CBE52583-B17C-446D-80B8-9E92B48E26ACQ35872691-4FC5B05A-EF33-4F57-849D-C3DC2BE5E21CQ36185611-3CC723E7-5BAA-41C1-84BC-D25BF2266821Q36195491-92E86CD9-B513-47C4-9649-29D56A21D9BBQ36245461-6ED823AA-09EB-48F7-8D0D-4C5DEC225060Q36289916-04FD039E-6734-468A-8B8D-0567A3186F92Q36334921-DEF5338D-3BC5-4547-8933-D2E512EDB685Q36429373-DFA5B451-892D-40F9-86BB-756C3B02B78FQ36740641-4058EE49-64C5-4916-AFC1-11CA70349C39Q37230098-601E07C1-EBE2-43E2-B537-3DED08F73DA0Q37329165-0A06D5D5-84E9-465C-AB05-E633B0320765Q37341664-0DE1C612-8A02-4AB2-8570-7BF0A6E2520CQ38091335-9CF73EEA-AFB2-4AB5-B0F9-CEC18FE63F51Q40020434-2FBB4B97-2585-44D7-B2DC-18FC7E6DDF01Q43042833-3FE9798A-4D48-43A6-97D5-4A9978EC376AQ44956846-79B59861-D26E-4A51-8AD5-40F429C9C49BQ46727663-94536CA4-4B04-4467-A094-76592C71B62AQ50515897-9BE547D0-15A1-465E-94E7-02E463DDDFC1Q52812855-4C5DE133-B1E3-4B51-8843-4C86FE4C5932Q55315083-EE2CE873-05BB-4758-A933-EAC964A12F6DQ57142375-2A50E43E-73B4-4BEC-9AF0-4AA5962E16F1
P2860
Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Gemcitabine as first-line ther ...... east cancer: a phase II trial.
@ast
Gemcitabine as first-line ther ...... east cancer: a phase II trial.
@en
type
label
Gemcitabine as first-line ther ...... east cancer: a phase II trial.
@ast
Gemcitabine as first-line ther ...... east cancer: a phase II trial.
@en
prefLabel
Gemcitabine as first-line ther ...... east cancer: a phase II trial.
@ast
Gemcitabine as first-line ther ...... east cancer: a phase II trial.
@en
P2093
P356
P1433
P1476
Gemcitabine as first-line ther ...... east cancer: a phase II trial.
@en
P2093
P356
10.1159/000048240
P577
2002-01-01T00:00:00Z